InvestorsObserver
×
News Home

Can Rocket Pharmaceuticals Inc (RCKT) Stock Rise to the Top of Healthcare Sector Monday?

Monday, March 11, 2024 12:04 PM | InvestorsObserver Analysts

Mentioned in this article

Can Rocket Pharmaceuticals Inc (RCKT) Stock Rise to the Top of Healthcare Sector Monday?

A rating of 92 puts Rocket Pharmaceuticals Inc (RCKT) near the top of the Healthcare sector according to InvestorsObserver. Rocket Pharmaceuticals Inc's score of 92 means that it ranks higher than 92% of stocks in the sector. In addition, its overall score of 90 ranks it higher than 90% of all stocks.

Overall Score - 90
RCKT has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on RCKT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 90 means the stock is more attractive than 90 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Rocket Pharmaceuticals Inc Stock Today?

Rocket Pharmaceuticals Inc (RCKT) stock is higher by 0.81% while the S&P 500 is down -0.26% as of 12:04 PM on Monday, Mar 11. RCKT is up $0.22 from the previous closing price of $27.87 on volume of 181,004 shares. Over the past year the S&P 500 is higher by 32.54% while RCKT is up 45.60%. RCKT lost -$2.92 per share the over the last 12 months. Click Here to get the full Stock Report for Rocket Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App